High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug responseHui Gao, Zongyao Wang, Chao Zhang et al.|Nature Medicine|2015Cited by 1.4k
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinasesYing-Nan P. Chen, Nicholas Keen, Matthew J. LaMarche et al.|Nature|2016Cited by 925
The metabolic function of cyclin D3–CDK6 kinase in cancer cell survivalHaizhen Wang, Piotr Siciński, Brandon Nicolay et al.|Nature|2017Cited by 354